People

Swedish DPI company Iconovo has announced the appointment of Roger Lassing as Vice President Business Development. Lassing, who was most recently Senior Manager of Global Business Development at LEO Pharma, has previously held executive positions at Takeda, Nycomed, and AstraZeneca, where he was Global Brand Manager for Symbicort. Over the past few years, Iconovo … [Read more...] about Iconovo appoints Roger Lassing as VP Business Development

Acorda Therapeutics has announced the appointment of Peter S. Carbone as Senior VP, Quality. Carbone was most recently VP of Quality Solids Americas & Special Technologies at Novartis and previously held executive positions at Amgen and Allergan. The FDA approved Acorda's Inbrija levodopa DPI for the treatment of OFF episodes in Parkinson’s disease patients in … [Read more...] about Acorda Therapeutics names Peter S. Carbone as Senior VP, Quality

Device company Nemera has announced the promotion of the leader of its Innovation Center, Dimitri Grasswill, to VP of Innovation. Grasswill has directed the Innovation Center, located in La Verpillière, France, since 2013. In a tweet announcing his promotion, Grasswill is quoted as saying "I am proud of leading a passionate and creative team of drug delivery … [Read more...] about Nemera promotes Dimitri Grasswill to VP of Innovation

Dance Biopharm, which is developing an insulin soft mist inhaler, has named Melissa Rhodes as Chief Development Officer and Michael Kaseta as its new Chief Financial Officer. The company said that former CFO Don Huffman will continue to act as an advisor. Rhodes was most recently Chief Development Officer at Roivant's Altavant Sciences and was previously Senior VP … [Read more...] about Dance Biopharm appoints new CFO and Chief Development Officer

Inhaler filling experts Harro Höfliger have announced a number of management changes after the retirement of its founder, Harro Höfliger, who has been succeeded by his son, Markus Höfliger as Chairman of the Supervisory Board. Markus Höfliger was formerly Chief Financial Officer; Turgay Güngormus will now take over as CFO. According to the company, Harro Höfliger … [Read more...] about Harro Höfliger announces management changes

Nanoform, which recently announced construction of a new GMP manufacturing facility in Helsinki, has announced the appointment of Niklas Sandler as Chief Technology Officer. Sandler was most recently Vice Rector responsible for Research Affairs and Professor of Pharmaceutical Technology at Åbo Akademi University, and he is Chairman of the Board of the Finnish … [Read more...] about Nanoform appoints Niklas Sandler as Chief Technology Officer

Verona Pharma, which is developing an inhaled PDE3/PDE4 inhibitor, has named Kathleen Rickard as Chief Medical Officer and Tara Rheault as VP of Research and Development Operations and Global Project Management. Rickard has previously served as Chief Medical Officer at Aerocrine, Head of Clinical Development at Circassia, and VP Clinical Development and Medical … [Read more...] about Verona Pharma names Kathleen Rickard as CMO and Tara Rheault as VP of R&D

Finnish nanotechnology company Nanoform has named Gonçalo Rebelo de Andrade, former Hovione Business Development Manager for inhalation and respiratory product development, as Chief of Business Operations. The company recently announced that it is building a new 600m2 GMP manufacturing facility in Helsinki. Andrade also served as Managing Director of Hovione … [Read more...] about Nanoform appoints Gonçalo Rebelo de Andrade as Chief of Business Operations

AOBiome Therapeutics, which is developing several intranasal ammonia oxidizing bacteria (AOB) candidates, said that Judith Ng-Cashin was appointed Chief Medical Officer as of October 1, 2018. Ng-Cashin was most recently Chief Scientific Officer at Syneos Health. She has also held a variety of executive positions at IQVIA (formerly Quintiles) and GSK. In April … [Read more...] about AOBiome Therapeutics names Judith Ng Cashin as Chief Medical Officer